The effects of cipepofol and propofol on hemodynamics and cardiac function in patients undergoing debridement after coronary artery bypass

INTERVENTION: Group C:Using cipepofol for anesthesia induction and maintenance;Group P:Using propofol for anesthesia induction and maintenance; CONDITION: Deep sternal wound infection PRIMARY OUTCOME: AUC; SECONDARY OUTCOME: Hemodynamic indicators;Dosage of vasoactive drugs;Quality of awakening;Cardiac injury markers;Adverse Reactions; INCLUSION CRITERIA: (1) Voluntarily participate in this study and sign the informed consent form; (2) Patients who have undergone coronary artery bypass surgery within the past 6 months and are planning to undergo thoracoplasty; (3) American Society of Anesthesiologists (ASA) classification level II to III; (4) Left ventricular ejection fraction (LVEF) >= 45%; (5) Age 18 years or older and 75 years or younger; (6) BMI 18 to 30 kg/m2